Sectra has received FDA clearance for its Digital Pathology Module, a primary diagnostics tool intended for U.S. healthcare providers.

Researchers have used machine learning to develop a blood test that can find 50 or so types of cancer.

U.S. hospitals were already facing falling margins when the COVID-19 pandemic began to ramp up in the nation.

A disease that hits most people mildly but some very hard—and so wreaks havoc with its unpredictability among the infected—would seem a good target for AI’s predictive prowess.

Louisiana is the most exposed state economy when it comes to the new coronavirus, COVID-19.

Researchers in South Korea have shown that AI trained on photos of both Asian and Caucasian patients can help dermatologists more accurately diagnose many diseases and disorders of the skin in both subpopulations.

CMS is allowing healthcare providers to react to the COVID-19 pandemic with greater flexibility by loosening some federal requirements and issuing sweeping new rules.

Venture capital firm General Catalyst and other investors are sinking $51 million into Columbus, Ohio-based Olive with the aim of growing the AI startup’s capacity for automating administrative processes in healthcare.

A healthcare AI company has spotted several unexpected, off-label drug combinations that may do the job against COVID-19. In any case, the company is offering its complete AI toolkit free of charge to drug developers working on COVID treatments.

Any interested party can now see state-by-state forecasts for peak hospitalization vs. capacity due to COVID-19 over the coming four months.